Breaking News Instant updates and real-time market news.

BMY

Bristol-Myers

$63.47

0.19 (0.30%)

18:33
12/13/17
12/13
18:33
12/13/17
18:33

Bristol-Myers granted exclusive license by Ono Pharma to develop ONO-4578

Bristol-Myers and Ono Pharmaceutical announced an agreement that grants Bristol-Myers Squibb an exclusive license for the development and commercialization of ONO-4578, Ono's selective Prostaglandin E2 receptor 4 antagonist. The companies will also collaborate on discovery efforts to identify additional compounds from Ono's PGE2 receptor antagonist programs. Under the terms of the agreement, Bristol-Myers Squibb will make an upfront payment of $40M to Ono. Bristol-Myers Squibb will be solely responsible for the development, manufacturing and commercialization of ONO-4578 as well as other PGE2 receptor antagonist products in all countries of the world except Japan, South Korea, Taiwan, China and Association of Southeast Asian Nations countries. Ono is eligible to receive subsequent clinical, regulatory and sales-based milestone payments, as well as royalties in these countries where Bristol-Myers Squibb has exclusive license. In Japan, South Korea and Taiwan, Bristol-Myers Squibb and Ono will partner on the development and commercialization under the companies' existing collaboration agreement, while in China and ASEAN countries, Ono will retain exclusive rights.

  • 18

    Jan

  • 05

    Mar

BMY Bristol-Myers
$63.47

0.19 (0.30%)

11/08/17
LEER
11/08/17
NO CHANGE
LEER
Outperform
Leerink sees Five Prime recovering some of yesterday's losses
After hosting an investor call to obtain additional information on the efficacy and safety profile of cabiralizumab in pancreatic cancer, Leerink analyst Michael Schmidt expects shares Five Prime Therapeutics (FPRX) will recover some of the losses from yesterday. The efficacy observed in yesterday's data look "quite promising," while safety looks very similar to what has been seen in Opdivo monotherapy trials historically, Schmidt tells investors in a research note. He notes that Five Prime partner Bristol-Myers (BMY) remains highly engaged in the cabiralizumab program. The analyst maintains an Outperform rating on Five Prime shares. The stock in midday trading is up 15%, or $3.85, to $29.71.
11/13/17
BMOC
11/13/17
NO CHANGE
BMOC
BMO says Pfizer buying Biogen makes more sense than deal for Bristol-Myers
BMO Capital analyst Alex Arfaei noted the "significant market speculation" that Pfizer (PFE) is preparing to execute a large M&A deal. While many sources, including Bloomberg, have speculated that Pfizer could target Bristol-Myers (BMY), Arfaei argues that a deal for Biogen (BIIB) would make more sense. He believes Pfizer has a significant gap in neurology, particularly in Alzheimer's, where it cannot afford to remain on the sidelines as its peers - including Biogen, Merck (MRK), AstraZeneca (AZN), and Eli Lilly (LLY) - all have pivotal trials in that area reading out in 2019-2020. Pfizer could have an opportunity to leverage near-term volatility in Biogen's MS franchise to strike a deal during the next 6-9 months before a potential interim look on aducanumab, which Arfaei views as the strongest of the next wave of Alzheimer's drugs in development, he tells investors.
11/30/17
GABE
11/30/17
NO CHANGE
Target $133
GABE
Buy
Incyte a top biotech pick for 2018 at Gabelli
Gabelli analyst Jing He highlighted Incyte as his top biotech pick for 2018 telling investors shares are undervalued and should benefit from the Epa melanoma data readout in first half 2018. The analyst said shares are trading near a 52-week low despite progress in the pipeline and believes competitors Bristol-Myers (BMY) and NewLink's (NLNK) IDO inhibitors are a few years behind Epa in development. Further, as tax reform gains more clarity, He believes M&A oncology deals could pickup and views Incyte as an attractive takeover target. Jing He rates Incyte a Buy with a $133 price target.
12/05/17
SBSH
12/05/17
NO CHANGE
Target $72
SBSH
Buy
Senate tax bill raises odds of Pfizer buying Bristol-Myers, says Citi
The Senate tax bill, which lowers the cost of bringing cash back home from outside the U.S., increases the probability of the "often-discussed" potential acquisition of Bristol-Myers Squibb (BMY) by Pfizer, Citi analyst Andrew Baum tells investors in a research note. The analyst points out that Pfizer has repeatedly underscored the importance of tax reform both from a competitive angle as well as from a merger perspective. Further, the analyst says that while Roche's (RHHBY) IMpower 150 Tecentriq lung cancer data in Geneva will take center stage this week, Bristol-Myers should benefit from two recent positive developments. The FDA's and Centers for Medicare and Medicaid Services' recommendation of Tumor Mutational Burden testing for lung cancer and other tumors will likely materially accelerate adoption and create more favorable reimbursement, Baum writes in a research note partially titled "Stars Converging for BMY." The analyst keeps a Buy rating on Bristol shares with a $72 price target. The stock closed yesterday down 76c to $62.47.

TODAY'S FREE FLY STORIES

EVOP

EVO Payments

$0.00

(0.00%)

10:21
05/23/18
05/23
10:21
05/23/18
10:21
Syndicate
Breaking Syndicate news story on EVO Payments »

EVO Payments indicated to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

MRK

Merck

$59.07

0.61 (1.04%)

10:20
05/23/18
05/23
10:20
05/23/18
10:20
Options
Short term call buyers in Merck lead puts 8:1 »

Short term call buyers in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 10

    Sep

  • 23

    Oct

CWH

Camping World

$20.09

-1.31 (-6.12%)

10:18
05/23/18
05/23
10:18
05/23/18
10:18
Hot Stocks
Camping World slides after reporting change in registered public accounting firm »

In a regulatory filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVOP

EVO Payments

$0.00

(0.00%)

10:17
05/23/18
05/23
10:17
05/23/18
10:17
Syndicate
EVO Payments indicated to open at $20.80, IPO priced at $16.00 »

EVO Payments (EVOP)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
05/23/18
05/23
10:17
05/23/18
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
05/23/18
05/23
10:16
05/23/18
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CWH

Camping World

$20.20

-1.2 (-5.61%)

10:13
05/23/18
05/23
10:13
05/23/18
10:13
Hot Stocks
Camping World slides after reporting change in registered public accounting firm »

In a regulatory filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMI

Kinder Morgan

$15.97

0.03 (0.19%)

10:10
05/23/18
05/23
10:10
05/23/18
10:10
Options
Bullish option flow in Kinder Morgan »

Bullish option flow in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JD

JD.com

$36.41

0.04 (0.11%)

10:05
05/23/18
05/23
10:05
05/23/18
10:05
Options
JD.com call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLNX

Xilinx

$68.97

-2.69 (-3.75%)

10:04
05/23/18
05/23
10:04
05/23/18
10:04
Technical Analysis
Technical Take: Xilinx falls after investor day »

The shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:03
05/23/18
05/23
10:03
05/23/18
10:03
General news
New Home Sales data reported »

April New Home Sales at…

TIF

Tiffany

$117.76

15.5 (15.16%)

10:01
05/23/18
05/23
10:01
05/23/18
10:01
Recommendations
Tiffany analyst commentary  »

Tiffany price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 24

    May

  • 26

    Jun

MGM

MGM Resorts

$31.57

-0.005 (-0.02%)

09:55
05/23/18
05/23
09:55
05/23/18
09:55
Options
MGM Resorts put volume heavy and directionally bearish »

Bearish flow noted in MGM…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TIF

Tiffany

$116.41

14.15 (13.84%)

, RL

Ralph Lauren

$126.98

10.31 (8.84%)

09:55
05/23/18
05/23
09:55
05/23/18
09:55
Options
Early notable gainers among liquid option names on May 23rd »

Notable gainers among…

TIF

Tiffany

$116.41

14.15 (13.84%)

RL

Ralph Lauren

$126.98

10.31 (8.84%)

LOW

Lowe's

$92.09

6.35 (7.41%)

URBN

Urban Outfitters

$42.69

1.48 (3.59%)

AAP

Advance Auto Parts

$117.04

1.72 (1.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 23

    May

  • 23

    May

  • 24

    May

  • 07

    Jun

  • 26

    Jun

PLAB

Photronics

$9.30

0.25 (2.76%)

09:55
05/23/18
05/23
09:55
05/23/18
09:55
Conference/Events
Photronics to hold an analyst and investor event »

Analyst and Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

09:55
05/23/18
05/23
09:55
05/23/18
09:55
Conference/Events
Senate Banking, Housing & Urban Affairs Committee to hold a hearing »

The Committee holds a…

HPP

Hudson Pacific

$34.14

-0.005 (-0.01%)

09:55
05/23/18
05/23
09:55
05/23/18
09:55
Conference/Events
Hudson Pacific to host two day analyst and investor day event »

Two day analyst and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

09:55
05/23/18
05/23
09:55
05/23/18
09:55
Conference/Events
Benchmark technology analyst to hold an analyst/industry conference call »

Analyst Mobley, hosts…

RL

Ralph Lauren

$126.44

9.77 (8.37%)

09:53
05/23/18
05/23
09:53
05/23/18
09:53
Technical Analysis
Technical Take: Ralph Lauren hits new 52-week high after earnings »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 07

    Jun

  • 26

    Jun

09:50
05/23/18
05/23
09:50
05/23/18
09:50
Hot Stocks
Breaking Hot Stocks news story  »

Rosehill Resources Inc…

ICE

IntercontinentalExchange

$71.75

(0.00%)

, FB

Facebook

$182.80

-1.01 (-0.55%)

09:48
05/23/18
05/23
09:48
05/23/18
09:48
Hot Stocks
NYSE to launch FANG+ options on June 11 »

The New York Stock…

ICE

IntercontinentalExchange

$71.75

(0.00%)

FB

Facebook

$182.80

-1.01 (-0.55%)

AMZN

Amazon.com

$1,567.93

-14.17 (-0.90%)

AAPL

Apple

$186.56

-0.72 (-0.38%)

NFLX

Netflix

$329.10

-2.52 (-0.76%)

GOOG

Alphabet

$1,065.97

-3.59 (-0.34%)

GOOGL

Alphabet Class A

$1,070.94

-4.37 (-0.41%)

BABA

Alibaba

$193.66

-2.28 (-1.16%)

BIDU

Baidu

$239.20

-0.73 (-0.30%)

NVDA

Nvidia

$241.00

-1.62 (-0.67%)

TSLA

Tesla

$277.70

2.69 (0.98%)

TWTR

Twitter

$32.80

-0.06 (-0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 30

    May

  • 03

    Jun

  • 04

    Jun

  • 27

    Jul

  • 10

    Sep

WLBA

Westmoreland Coal

$0.00

(0.00%)

, WMLP

Westmoreland Resource Partners

$1.34

0.03 (2.29%)

09:47
05/23/18
05/23
09:47
05/23/18
09:47
Hot Stocks
Westmoreland Coal reports securing $110M in new financing »

Westmoreland Coal (WLBA)…

WLBA

Westmoreland Coal

$0.00

(0.00%)

WMLP

Westmoreland Resource Partners

$1.34

0.03 (2.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPE

HP Enterprise

$16.79

-0.7 (-4.00%)

09:47
05/23/18
05/23
09:47
05/23/18
09:47
Technical Analysis
Technical Take: HP Enterprise at session lows after results »

The company reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 11

    Jun

  • 10

    Jul

09:45
05/23/18
05/23
09:45
05/23/18
09:45
Hot Stocks
Breaking Hot Stocks news story  »

Rosehill Resources Inc…

09:45
05/23/18
05/23
09:45
05/23/18
09:45
General news
New Home Sales to be reported at 10:00 »

April New Home Sales will…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.